NanoFlu And ResVax: Make Or Break For Novavax

NanoFlu And ResVax: Make Or Break For Novavax

In 2016, a Respiratory Syncytial Virus (RSV) vaccine candidate named the RSV F Vaccine failed in Phase III trials, which could have been a crippling blow for Novavax, but they may be on the road to…